At the time of writing, Longboard Pharmaceuticals Inc [LBPH] stock is trading at $34.19, up 4.08%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The LBPH shares have lost -1.98% over the last week, with a monthly amount drifted -1.95%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Longboard Pharmaceuticals Inc [NASDAQ: LBPH] stock has seen the most recent analyst activity on July 01, 2024, when Cantor Fitzgerald reiterated its Overweight rating and also boosted its price target to $90 from $60. Previously, Robert W. Baird started tracking the stock with Outperform rating on May 01, 2024, and set its price target to $36. On February 16, 2024, Citigroup initiated with a Buy rating and assigned a price target of $40 on the stock. B. Riley Securities initiated its recommendation with a Buy and recommended $13 as its price target on April 27, 2023. Evercore ISI started tracking with a Outperform rating for this stock on April 07, 2021, and assigned it a price target of $35. In a note dated April 06, 2021, Guggenheim initiated an Buy rating and provided a target price of $27 on this stock.
For the past year, the stock price of Longboard Pharmaceuticals Inc fluctuated between $3.60 and $40.48. Currently, Wall Street analysts expect the stock to reach $44.5 within the next 12 months. Longboard Pharmaceuticals Inc [NASDAQ: LBPH] shares were valued at $34.19 at the most recent close of the market. An investor can expect a potential return of 30.16% based on the average LBPH price forecast.
Analyzing the LBPH fundamentals
Gross Profit Margin for this corporation currently stands at 0.38% with Operating Profit Margin at -9113.5%, Pretax Profit Margin comes in at -8092.25%, and Net Profit Margin reading is -8092.25%. To continue investigating profitability, this company’s Return on Assets is posted at -0.21, Equity is -0.37 and Total Capital is -0.24. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 31.10 points at the first support level, and at 28.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 35.77, and for the 2nd resistance point, it is at 37.34.
Ratios To Look Out For
It is important to note that Longboard Pharmaceuticals Inc [NASDAQ:LBPH] has a current ratio of 20.95. Also, the Quick Ratio is 20.95, while the Cash Ratio stands at 0.99.
Transactions by insiders
Recent insider trading involved ARENA PHARMACEUTICALS INC, Former 10% Owner, that happened on Jan 25 ’24 when 3.98 million shares were sold.
